ArticleProceedings of the National Academy of Sciences of the United States of America2019

TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion.

Naveen Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.